检索结果 - Kohei Nakachi
- Showing 1 - 9 results of 9
-
1
A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT) 由 Kohei Nakachi, Masaru Konishi, Masafumi Ikeda, Junki Mizusawa, Junko Eba, Takuji Okusaka, Hiroshi Ishii, Haruhiko Fukuda, Junji Furuse
出版 2018Artigo -
2
-
3
Long-term survival and prognosis associated with conversion surgery in patients with metastatic gastric cancer 由 Einama, Takahiro, Abe, Hironori, Shichi, Shunsuke, Matsui, Hiroki, Kanazawa, Ryo, Shibuya, Kazuaki, Suzuki, Takashi, Matsuzawa, Fumihiko, Hashimoto, Taku, Kohei, Nakachi, Homma, Shigenori, Kawamura, Hideki, Taketomi, Akinobu
出版 2017Text -
4
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan 由 Takuji Okusaka, Kohei Nakachi, Akira Fukutomi, Nobumasa Mizuno, S. Ohkawa, A Funakoshi, Masato Nagino, Satoshi Kondo, Soshi Nagaoka, Jumpei Funai, Minori Koshiji, Yoshihiro Nambu, Junji Furuse, Masaru Miyazaki, Y Nimura
出版 2010Artigo -
5
Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytes 由 Daisuke Nobuoka, Yutaka Motomura, Hirofumi Shirakawa, Toshiaki Yoshikawa, Toshimitsu Kuronuma, Mari Takahashi, Kohei Nakachi, Hiroshi Ishii, J. Furuse, Naoto Gotohda, Shinichiro Takahashi, Toshio Nakagohri, Masaru Konishi, Taira Kinoshitá, Hiroyuki Komori, Hideo Baba, Toshiyoshi Fujiwara, Tetsuya Nakatsura
出版 2011Artigo -
6
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival 由 Yu Sawada, Toshiaki Yoshikawa, Daisuke Nobuoka, Hirofumi Shirakawa, Toshimitsu Kuronuma, Yutaka Motomura, Shoichi Mizuno, Hiroshi Ishii, Kohei Nakachi, Masaru Konishi, Toshio Nakagohri, Shinichiro Takahashi, Naoto Gotohda, Tadatoshi Takayama, Kenji Yamao, Katsuhiko Uesaka, Junji Furuse, Taira Kinoshitá, Tetsuya Nakatsura
出版 2012Artigo -
7
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients 由 Yu Sawada, Toshiaki Yoshikawa, Kazuya Ofuji, Mayuko Yoshimura, Nobuhiro Tsuchiya, Mari Takahashi, Daisuke Nobuoka, Naoto Gotohda, Shinichiro Takahashi, Yuichiro Kato, Masaru Konishi, Taira Kinoshitá, Masafumi Ikeda, Kohei Nakachi, Naoya Yamazaki, Shoichi Mizuno, Tadatoshi Takayama, Kenji Yamao, Katsuhiko Uesaka, Junji Furuse, Itaru Endo, Tetsuya Nakatsura
出版 2016Artigo -
8
Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study 由 Kiwamu Okita, Namiki Izumi, Osamu Matsui, Katsuaki Tanaka, Shuichi Kaneko, Hisataka Moriwaki, Kenji Ikeda, Yukio Osaki, Kazushi Numata, Kohei Nakachi, Norihiro Kokudo, Kazuho Imanaka, Shuhei Nishiguchi, Takuji Okusaka, Yoichi Nishigaki, Susumu Shiomi, Masatoshi Kudo, Kenichi Ido, Yoshiyasu Karino, Norio Hayashi, Yasuo Ohashi, Masatoshi Makuuchi, Hiromitsu Kumada
出版 2014Artigo -
9
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407) 由 Masato Ozaka, Kohei Nakachi, Satoshi Kobayashi, Akihiro Ohba, Hiroshi Imaoka, Takeshi Terashima, Hiroshi Ishii, Junki Mizusawa, Hiroshi Katayama, Tomoko Kataoka, Takuji Okusaka, Masafumi Ikeda, Naoki Sasahira, Haruo Miwa, Eishiro Mizukoshi, Naohiro Okano, Nobumasa Mizuno, Tomohisa Yamamoto, Yoshito Komatsu, Akiko Todaka, Ken Kamata, Masayuki Furukawa, Nao Fujimori, Akio Katanuma, Yukiko Takayama, Hidetaka Tsumura, Haruhiko Fukuda, Makoto Ueno, Junji Furuse
出版 2022Artigo
相关主题
Internal medicine
Medicine
Gastroenterology
Oncology
Cancer
Surgery
Clinical endpoint
Hepatocellular carcinoma
Randomized controlled trial
Gemcitabine
Glypican 3
Immunology
Pathology
Ablation
Adjuvant
Adjuvant therapy
Adverse effect
Alternative medicine
Carcinoembryonic antigen
Chemotherapy
Clinical trial
Epitope
Immune system
Immunotherapy
Pancreatic cancer
Peptide vaccine
Phases of clinical research
Placebo
Radiofrequency ablation
Regimen